 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Better Therapeutics (NASDAQ:BTTX Get Free Report) and EUDA Health (NASDAQ:EUDA Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ...

Better Therapeutics (NASDAQ:BTTX) vs. EUDA Health (NASDAQ:EUDA) Head to Head Comparison

In a report released today, Rahul Rakhit from LifeSci Capital maintained a Hold rating on Better Therapeutics, Inc. (BTTX Research Report). The c... In a report released today, Rahul Rakhit from LifeSci Capital maintained a Hold rating on Better Therapeutics, Inc. (BTTX &#8211...

LifeSci Capital Sticks to Its Hold Rating for Better Therapeutics, Inc. (BTTX)

Chardan Capital reissued their buy rating on shares of Better Therapeutics (NASDAQ:BTTX  Free Report) in a research report released on Thursday morning, Benzinga reports. They currently have a $9.00 target price on the stock. Separately, Lake Street Capital cut their target price on Better ...

Better Therapeutics (NASDAQ:BTTX) Receives Buy Rating from Chardan Capital

Better Therapeutics (NASDAQ:BTTX Free Report) had its price objective decreased by Lake Street Capital from $5.00 to $3.00 in a research report sent to investors on Thursday morning, MarketBeat reports. Lake Street Capital currently has a buy rating on the stock. Separately, Chardan Capital ...

Lake Street Capital Lowers Better Therapeutics (NASDAQ:BTTX) Price Target to $3.00

Better Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation

Better Therapeutics GAAP EPS of -$0.24 beats by $0.07

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today reported financial results for the second quarter 2023 and provided an update on progress towards achieving key corporate milestones. Obtaining FDA...

Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

Better Therapeutics, Inc. (NASDAQ:BTTX  Get Free Report) insider Mark A. Berman bought 54,802 shares of the firms stock in a transaction that occurred on Thursday, July 27th. The shares were acquired at an average cost of $0.73 per share, for a total transaction of $40,005.46. ...

Insider Buying: Better Therapeutics, Inc. (NASDAQ:BTTX) Insider Buys 54,802 Shares of Stock

Better Therapeutics, Inc. (NASDAQ:BTTX Get Free Report) Director Andrew J. Armanino acquired 274,010 shares of the firms stock in a transaction on Thursday, July 27th. The stock was purchased at an average price of $0.73 per share, for a total transaction of $200,027.30. Following the completion of ...

Better Therapeutics, Inc. (NASDAQ:BTTX) Director Buys $200,027.30 in Stock

Better Therapeutics, Inc. (NASDAQ:BTTX  Get Free Report) Chairman David P. Perry acquired 1,233,045 shares of the stock in a transaction dated Thursday, July 27th. The stock was bought at an average price of $0.73 per share, for a total transaction of $900,122.85. Following the completion of ...

Better Therapeutics, Inc. (NASDAQ:BTTX) Chairman David P. Perry Buys 1,233,045 Shares

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.

Watchers	3,167
52-Wk Low	$0.3202
52-Wk High	$1.86

Market Cap	$14.2M
Volume (M)	27,310.00
52-Wk High	$1.86
52-Wk Low	$0.3202

BTTX Better Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals